Mitochondrial dysfunction and reactive oxygen species (ROS) play critical roles in disease processes from ischemic AKI, to immune response and inflammation, diabetes, obesity, metabolic syndrome, aging, neurodegenerative and cardiovascular diseases. Therefore, elucidating mechanisms of mitochondrial dysfunction is key to understanding the pathophysiology of many disease processes. Using the ischemia/reperfusion (I/R) kidney injury model to characterize mitochondrial pathways for kidney protection, we identified stanniocalcin-1 (STC1) as a potential therapeutic target. STC1 is a mitochondrial intracrine molecule (defined as an extracellular signaling molecule that enters cells, translocates to mitochondria and alters their function). STC1 activates AMPK, which in turn upregulates uncoupling proteins (UCPs) and SIRT3, promoting mitochondrial anti-oxidant defenses. Transgenic overexpression of STC1 confers resistance to IR kidney injury. The mechanism whereby intracrines such as STC1 are translocated to mitochondria is unknown. We have identified the multi-ligand receptor megalin as a trafficking vehicle for STC1 from the cell surface to mitochondria via the retrograde early endosome-to-Golgi. Megalin KO in cultured cells decreases the expression of SIRT3, diminishes mitochondrial respiration and glycolysis, and increases susceptibility to ischemic kidney injury. This proposal will examine the hypotheses that: megalin is critical for mitochondrial biology; KO of megalin aggravates ischemic kidney injury; and mitochondrial targeting of STC1 is required for STC1-mediated cytoprotection.
Aim 1 A will determine the phenotype of ischemia/reperfusion kidney injury in mice with doxycycline-inducible and tubular epithelium-specific knockout of megalin.
Aim 1 B will characterize the mitochondrial phenotype in cultured proximal tubule cells with megalin KO, at baseline and following hypoxia/reoxygenation.
Aim 2 A will determine whether mitochondrial targeting of STC1 is required for STC1-mediated cytoprotection in vitro.
Aim 2 B will determine whether mitochondrial targeting of STC1 is required for STC1-mediated cytoprotection in vivo. Our proposed studies will elucidate the role of megalin and STC1 in mitochondrial function and may offer fundamental insights into the pathogenesis of diseases where mitochondrial dysfunction is critical.

Public Health Relevance

Mitochondrial dysfunction and reactive oxygen species play important roles in many disease processes from acute kidney injury, to inflammation, diabetes, obesity, aging, neurodegenerative and cardiovascular diseases. The naturally occurring anti-oxidant protein stanniocalcin-1 protects the kidneys from ischemic damage. It is carried to the mitochondria by megalin, and the current proposal will examine mitochondrial targeting of stanniocalcin-1 by megalin and its impact on kidney protection.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Non-HHS Research Projects (I01)
Project #
5I01BX002006-06
Application #
9838089
Study Section
Special Emphasis Panel (ZRD1)
Project Start
2014-04-01
Project End
2022-12-31
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Michael E Debakey VA Medical Center
Department
Type
DUNS #
078446044
City
Houston
State
TX
Country
United States
Zip Code
77030
Lin, Ligen; Lee, Jong Han; Buras, Eric D et al. (2016) Ghrelin receptor regulates adipose tissue inflammation in aging. Aging (Albany NY) 8:178-91
Pan, Jenny Szu-Chin; Sheikh-Hamad, David (2015) Remote Ischemic Preconditioning and Postoperative Renal Dysfunction--Reply. JAMA 314:1520
Huang, Luping; Lou, Yahuan; Ju, Huiming et al. (2015) Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1. PLoS One 10:e0138440
Pan, Jenny Szu-Chin; Huang, Luping; Belousova, Tatiana et al. (2015) Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. J Am Soc Nephrol 26:364-78
Scherzer, Pnina; Gal-Moscovici, Anca; Sheikh-Hamad, David et al. (2015) Sodium-pump gene-expression, protein abundance and enzyme activity in isolated nephron segments of the aging rat kidney. Physiol Rep 3:
Huang, Luping; Zhang, Lin; Ju, Huiming et al. (2015) Stanniocalcin-1 inhibits thrombin-induced signaling and protects from bleomycin-induced lung injury. Sci Rep 5:18117
Pan, Jenny Szu-Chin; Sheikh-Hamad, David (2015) Remote ischemic preconditioning for kidney protection. JAMA 313:2124-5
Lin, Ligen; Lee, Jong Han; Bongmba, Odelia Y N et al. (2014) The suppression of ghrelin signaling mitigates age?associated thermogenic impairment. Aging (Albany NY) 6:1019-32
Huang, Luping; Belousova, Tatiana; Pan, Jenny Szu-Chin et al. (2014) AKI after conditional and kidney-specific knockdown of stanniocalcin-1. J Am Soc Nephrol 25:2303-15